Clinical Trial Update: Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib added to chemotherapy for Philadelphia chromosome–positive acute lymphoblastic leukemia in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Rennes University Hospital | Conditions: Acute Lymphoblastic Leukemia, Philadelphia Chromosome | Phase 2 | Status: COMPLETED